Dermata Therapeutics, Inc. (DRMA) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$7.77M | +37.9% |
| 2024 | -$12.51M | -55.6% |
| 2023 | -$8.04M | +16.9% |
| 2022 | -$9.67M | -23.1% |
| 2021 | -$7.86M | -147.6% |
| 2020 | -$3.17M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$7.77M | +37.9% |
| 2024 | -$12.51M | -55.6% |
| 2023 | -$8.04M | +16.9% |
| 2022 | -$9.67M | -23.1% |
| 2021 | -$7.86M | -147.6% |
| 2020 | -$3.17M | — |